Richard Drake, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
Indiana University
Medical School
Western Michigan University Homer Stryker M.D.
Internship
Ohio State University Hospital
Residency
American Board of Internal Medicine - Oncology
OH State Medical License: 1987 - 2019
American Board of Pathology: Anatomic Pathology & Clinical Pathology
American Board of Pathology: Pediatric Pathology
CLEVELAND CLINIC HOSPITAL
Languages: English/Spanish
(216) 445-0150
9500 Euclid Ave Taussig Cancer Institute
Read MoreA phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
Herzog, T. J.,Monk, B. J.,Rose, P. G.,Braly, P.,Hines, J. F.,Bell, M. C.,Wenham, R. M.,Secord, A. A.,Roman, L. D.,Einstein, M. H.,Drake, R. D.,Childs, B. H.; Gynecol. Oncol.. 2014 Jan 31.
See more >>Mural nodules of clear cell carcinoma in a mucinous borderline tumor of the ovary: a case report
Allende, D. S., Drake, R. D., Chen, L.; Patholog Res Int. 2010.
See more >>A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecolog...
Miller, D.S., Blessing, J.A., Drake, R.D., Higgins, R., McMeekin, D.S., Puneky, L.V., Krasner, C.N.; Gynecol Oncol. 2009-12-01.
See more >>